Emergency Guidelines
SfE Emergency Guidance for Hypocalcaemia & Hypercalcaemia
Emergency Guidance for Acute Hypocalaemia
Emergency Guidance for Acute Hypercalcaemia
Hypoparathyroidism Guidelines
Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults
Jens Bollerslev, Ottilia Buch,Luís Miguel Cardoso, Neil Gittoes, Pascal Houillier, Leonie van Hulsteijn, Ozer Makay, Claudio Marcocci, J Carl Pallais, Stefan Pilz, Lars Rejnmark, Maria Yavropoulou, Olaf M DekkersEuropean Journal of Endocrinology, Volume 193, Issue 5, Nov 2025, Pages G49–G78, https://doi.org/10.1093/ejendo/lvaf222
Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop
Aliya A.Khan, John P.Bilezikian, Maria Luisa Brandi, Bart L.Clarke, Neil.Gittoes, Janice L.Pasieka, LarsRejnmark, Dolores M.Shoback, JohnT.Potts, GordonH.Guyatt, Michael Mannstadt
JBMR Vol.00,No.00,Month2022,pp1–18. DOI:10.1002/jbmr.4691 2022
Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus Aliya A Khan et al, EJE Vol 190 Issue 3 p1-22 March 2019
Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management
Aliya A Khan et al, EJE Vol 180, Issue 2, Feb 2019, Pages R37–R44
Management of Hypoparathyroidism: Summary Statement and Guidelines
JCEM Volume 101, Issue 6, 1 June 2016, 2273–2283
European Society for Endocrinology(ESE) Clinical Guideline: Treatment of Chronic Hypoparathyroidism in Adults
Bollerslev et al, EJE 173:2 July 2015
BAETS Post Thyroidectomy Hypocalcaemia Guidelines
Data from the UK Registry of Endocrine and Thyroid Surgery (www.baets.org.uk/audit) shows that post thyroidectomy hypocalcaemia rates can reach 27%.
Read the BAETS Post op hypocalcaemia management guidance here
Primary Hyperparathyroidism Guidelines
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop
John P. Bilezikian, Aliya A. Khan, Shonni J. Silverberg, Ghada El-Hajj Fuleihan, Claudio Marcocci, Salvatore Minisola, Nancy Perrier, Antonio Sitges-Serra, Rajesh V. Thakker, Gordon Guyatt, Michael Mannstadt, John T. Potts, Bart L. Clarke, Maria Luisa Brandi JBMR Aug 2022
NICE guidelines on Primary Hyperparathyroidism
Nice guideline (NG132) 23rd May 2019
Parathyroid UK helped to develop this guideline which covers diagnosing, assessing and managing primary hyperparathyroidism. It aims to improve recognition and treatment of this condition, reducing long‑term complications and improving quality of life.
COVID-19 Guidelines
Survey of COVID19 experiences by 570 patients
Liz Glenister Nov 2020
Summary of our COVID survey
Tom Kurzawinski May 2021
COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
Endocrine, M. Puig-Domingo, M. Marazuela, B.Yildiz, A.Giustina April 2021
Society for Endocrinology Planning & recommendations for COVID-19 second wave
* Prioritise severe or symptomatic hypercalcaemia and hypocalcaemia
Endocrinology in the time of Covid-19: Management of calcium metabolic disorders and osteoporosis
EJE bioscientifica, Gittoes et al, May 2020
Society for Endocrinology (SfE) COVID-19 resources for managing endocrine conditions
Coronavirus and parathyroid conditions FAQs
Template letter to give to your patients with hypoparathyroidism